A short statement has been released by BIVDA’s Chief Operating Officer Helen Dent on the COVID-19 border closures.

Helen said;

“Similarly to pharmaceutical companies, BIVDA members have planned contingencies in place for border emergencies in line with business continuity planning, which includes buffer stock and the ability to re-route supplies. Therefore, the provision of Diagnostic testing supplies will continue. We continue to monitor events and suppliers are working with the UK Government as required.”

ENDS

For more information please contact the BIVDA External Affairs team at michael@bivda.org.uk